The developmental origin of interferon-producing plasmacytoid dendritic cells ( 
Introduction
Plasmacytoid dendritic cells (pDC) are a subset of dendritic cells (DC) that circulate through the blood and peripheral tissues 1, 2 The developmental origin of pDC has long been unclear. Early studies showed that both common myeloid progenitors (CMP) and common lymphoid progenitors (CLP) had the potential, upon transfer into irradiated mice, to produce pDC 6, 7 , although it was unclear whether these potentials were expressed in steady state. Similar potential has been found in CLP and CMP from human cord blood 8 . Later it was shown that some pDC in the bone marrow (BM) and spleen of un-manipulated mice had expressed recombination activating gene 1 (RAG1) 9 and possessed D-J rearranged genes at the immunoglobulin heavy chain (IgH) locus 9, 10 . Such gene rearrangement events have been considered as indicators of a lymphoid developmental history. A recent paper described a cell intrinsic requirement for IL-7 signaling in the development of a subset of both splenic cDC and pDC, and concluded some DC were normally of lymphoid origin 11 . Taken together, these results suggested that the pDC found in normal mice had two different origins, from myeloid and from lymphoid progenitors.
However, in a subsequent study, IgH gene rearrangements were found in pDC derived after transfer from CMP as well as CLP 12 . The authors concluded that the IgH gene rearrangements were not necessarily markers of a lymphoid developmental history, but rather an accidental by-product of the similarity in transcriptional programs between B cells and pDC. In addition, a precursor restricted to production of pDC and conventional DC (cDC), termed a common dendritic cell precursor (CDP) or pro-DC, has been isolated from BM 13, 14 . The CDP is downstream of the CMP 13 and so is considered a myeloid lineage cell. As a result of these findings, only the myeloid origin of pDC tends to be
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To investigate in detail the pathway of pDC differentiation, we have used a BM culturwe system driven by fms-like tyrosine kinase 3 ligand (FL) [15] [16] [17] . We have previously demonstrated that this system models the pathway of steady state spleen DC development, including production of pDC and cDC from a CDP intermediate 14 . 
Materials and Methods

Mice
Unless otherwise indicated, experiments were performed using C57BL/6J Wehi (CD45.2) mice 6-12 weeks of age. Where indicated, C57BL/6-RAG1 tm1/lmku (RAG1-GFP) or C57BL/6J TG30Scha/J (UBC-GFP) mice were used as the source of precursors. C57BL/6
Pep 3b (CD45.1) mice were used as the source of BM feeder cells for cultures. Mice were bred under specific pathogen free conditions at the Walter and Eliza Hall Institute in accordance with the guidelines of the Animal Ethics Committee.
Monoclonal antibodies
Unless otherwise stated, antibodies were generated, purified and conjugated in house. The Culture system for B cell development OP9 cells (4000) were plated into wells of 96-well flat-bottomed culture plates.
Isolation of precursor cells from BM
Progenitors (<1000) were cultured in modified MEM with 50mM β -mercaptoethanol, 10% fetal calf serum, FL (5ng/mL) and 2% of the supernatant of an IL-7 producing line.
Cultures were harvested at 7 days and analyzed for CD19 + B cells, CD11c
and CD11c
Culture system for NK cell development OP9 cells (80000) were plated into wells of 24-well flat-bottomed culture plates and allowed to adhere. CLP (2000) or up to 15000 progenitors were cultured in IMDM with 50mM β -mercaptoethanol, 10% fetal calf serum, 50ng/mL IL-15, 50ng/mL SCF and 5ng/mL FL. Half the medium and the cytokines were replenished after 4 days of culture.
Cultures were harvested at 6 and 14 days and analyzed for the presence of 
PCR analysis for IgH gene rearrangements
PCRs for IgH rearrangements were performed as described previously 18 . Sorted cells were washed with PBS then re-suspended at 10 6 cells/ml in PCR lysis buffer.
Amplification of the RAG1 gene served as a template concentration control. DNA was titrated to give an equivalent amount of product in the control reactions, and to ensure that reactions were performed within the linear range. D to J rearrangements were detected as amplified fragments of ~1,033, ~716, or ~333 nucleotides depending on whether JH1, JH2, or JH3 was rearranged. PCR products were quantified using a Molecular Dynamics PhosphorImager (Sunnyvale, CA). PCR products were detected and quantified by Southern blotting and hybridization with appropriate Ig gene probes.
Assay for IFNα production
Progenitors were isolated and re-cultured with FL and BM feeders or transferred into irradiated recipients as above. Progenitor-derived pDC were sorted and re-cultured at 10 6 cells/mL with 0.5μM CpG2216 (Proligo). After 20 hours, culture supernantants were harvested and the concentration of IFNα analyzed by ELISA as previously described 19 .
The capture antibody was RMMA-1 (PBL InterferonSource). Polyclonal rabbit anti-IFNα (PBL InterferonSource) followed by anti-rabbit antibodies conjugated to horseradish peroxidase were used for detection. The reaction was visualized by the addition of ABTS.
The optical density was read with a Kinetic microplate reader set to 405-490 nm (Molecular Devices). Cytokine concentrations were interpolated from a standard curve.
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Results
Kinetics of pDC development
To investigate the development of pDC in detail, we used FL driven BM cultures that model steady-state DC development. We determined the kinetics of new pDC production from total BM that had been depleted of BST-2 + cells, to remove the population of preexisting pDC. The peak of pDC production occurred at day 6, earlier than the peak of cDC production at day 8 ( Fig.1a) . We had previously demonstrated that in these cultures CDP numbers peak at day 3
14
. Peak production of cDC from CDP occurred at day 5 upon re-culture, consistent with these precursors being the source of the day 8 cDC peak in the standard cultures. Although pDC are produced on re-culture of CDP
, the early peak of pDC development in the total BM cultures made it unlikely this myeloid route via CDP was the only source of pDC. We postulated that the pDC produced in these cultures derived from both myeloid and lymphoid precursors, as previously suggested 7,9,10 .
To investigate whether this might explain the kinetics of pDC development, we isolated CLP 20 and CMP 21 from BM according to the surface markers originally described and analyzed the kinetics of DC generation from each precursor. CMP produced both cDC and pDC. The main peak of pDC production from CMP occurred at day 7 (Fig. 1b) , consistent with a myeloid pathway in which CMP give rise to CDP, which in turn produce both pDC and cDC. In contrast, CLP produced predominantly pDC and the peak of production occurred earlier, at day 5 (Fig 1c) , suggesting such a lymphoid pathway might be responsible for much of the pDC generated in these cultures. cDC production from CLP varied greatly (data not shown), ranging from undetectable to 15% of the total DC progeny. The pDC produced from both precursors displayed the typical pDC surface phenotype, namely expressing high levels of CD11c, BST-2 (CD317), CD45R (B220) and CD45RA and Siglec H (Fig 1d) . These markers were subsequently used interchangeably to define pDC depending on particular fluorochrome and mAb staining combinations. Thus, in this model of steady state DC development, pDC developed via both lymphoid and myeloid intermediates. 
Production of pDC clones
To assay the developmental potential of different precursors, we had previously devised a clonal assay in which single GFP-expressing precursors were cultured with FL and BM feeder cells 14 . Using this assay we had compared clones derived from CDP (a DC restricted, late myeloid precursor) with those derived from LSK cells (enriched for early multipotent precursors). We found that while 25% of the DC clones derived from CDP contained pDC, almost all of these included cDC (Table 1) . However when LSK cells were used as precursors, giving the possibility of both myeloid and lymphoid developmental options, DC clones consisting of only pDC were prevalent. Of the 77% of DC clones containing pDC, almost 10% contained only pDC (Table 1) . We reasoned that these pure pDC clones must have been generated from a pathway not involving the CDP intermediate, likely a lymphoid pathway. However, single CLP showed too low a cloning efficiency for analysis by this assay.
An immediate pDC precursor on the lymphoid pathway
As we had found that CLP gave rise to pDC in FL BM cultures, we attempted to map this lymphoid pathway downstream of the CLP. CLP were isolated from BM and cultured with FL and the cultures analyzed at various time points to determine intermediate stages en route to pDC. We noted the emergence after 1-2 days, then disappearance by 3 days, of a population that differed from CLP in expressing BST-2, a pDC marker, but did not yet express the pan-DC marker CD11c (Fig 2a) . To determine the fate of this CD11c -BST-2 + CLP-derived population, it was sorted from cultures at day 2 then re-cultured with FL. After 1-2 days of re-culture, CD11c + BST-2 + pDC appeared and constituted most of the cells recovered, though a minor population of cDC was also produced (Fig 2b) .
However it was not clear whether all cells with the CD11c The precursors were isolated from cultures, then re-cultured under conditions known to be optimal for the generation of B cells or NK cells. After 7 days of culture these precursors produced B cells (Fig 2c) . However, the progeny of the CD11c constituting 0.15% of the BM. Most of these also expressed IL-7Rα, suggesting they were lymphoid-derived (Fig 2d) . To determine whether these cells were developmentally distinct from CLP, we adoptively transferred them into lethally irradiated congenic recipients. Very few progenitor-derived cells were detectable in recipient BM between day 6 and 14 after transfer but within the spleen we found progenitor-derived pDC, B cells and some cDC (Fig 2e) . No significant production of NK cells was seen at any time point, but a marginal production of T cells was seen at day 14. Overall the BM CD11c CLP-derived pDC uniformly showed some level of GFP expression (Fig. 3a) , indicating that at some point in their developmental history they had expressed RAG1. Interestingly, while most CMP-derived pDC were GFP negative, a subset had detectable GFP expression (Fig. 3b) . Thus, in agreement with the analysis of IgH gene rearrangements 12 To investigate the possibility of a subset of CMP with some lymphoid characteristics, we examined the CMP from RAG1-GFP mice. We found both RAG1 + and RAG1 -subsets within the CMP fraction, and these were entirely within the Flt3 expressing fraction known to contain the DC precursors 7 ( Fig. 4a) . The RAG1 + Flt3 + CMP subset retained myeloid potential, since it produced macrophages with high efficiency after 7 days of culture with GM-CSF (Fig. 4b) , whereas CLP did not produce any macrophages (data not shown). The Flt3 + , RAG1 + and RAG1 -subsets of CMP were sorted and cultured with congenic BM cells and FL, then the progeny DC analyzed. Both subsets gave rise to both pDC and cDC. The cDC derived from either subset had no detectable GFP fluorescence, indicating that any initial RAG1 expression had not persisted. However the pDC derived from the RAG1 + subset still had GFP expression whereas the pDC derived from the RAG1 -subset had no detectable GFP fluorescence (Fig. 4c) . Thus, a history of RAG1 expression in CMP-derived pDC largely reflected development from a progenitor already expressing RAG1.
Most pDC with IgH gene rearrangements derive from RAG1 + precursors
We had found in previous experiments that the DC produced in our cultures were similar in IgH gene rearrangement status to the DC from normal mouse spleen 10 ; a proportion of the pDC displayed D-J rearrangements, whereas the cDC were all in germline state. We had assumed D-J IgH gene rearrangements in pDC indicated development from a lymphoid precursor, and such D-J rearrangements in pDC had been shown to correlate (Fig. 5a ). The few pDC derived from the RAG1 + CMP also displayed D-J rearrangements. The pDC derived from the RAG1 -CMP usually did not display D-J rearrangements (Fig. 5a ). However in occasional experiments D-J rearrangements were revealed even in the pDC from the RAG1 -CMP fraction (e.g. Fig. 5b ). We suggest this reflects a low frequency of rearrangement events not always detected with this nonquantitative PCR assay. We concluded that pDC with D-J rearrangements in IgH genes generally derived from progenitors already expressing RAG1 as had been suggested 9 , but that the downstream process of pDC development does sometimes allow "ectopic"
lymphoid-like rearrangement events, as had been proposed 12 .
Type 1 interferon production by myeloid and lymphoid derived pDC
The ability to produce large amounts of type 1 interferon when appropriately stimulated is a key characteristic of pDC 1 . The RAG1 + and RAG1 -subsets of splenic pDC had previously been found to differ in the quantity of IFNα they produced following CpG stimulation 9 , suggesting that developmentally distinct pDC may differ in this function.
The pDC produced in vivo by adoptive transfer of CMP and CLP 7 had not been tested for IFN production, so their identification as "true" pDC had been questioned 12 . Since in our cultures multiple pathways produced cells with a pDC surface phenotype, we examined whether these pDC differed in this key function. The pDC derived in culture from total BM, from CMP or CDP or CLP were purified, then compared for their ability to produce
INFα in culture in response to CpG stimulation.
When the pDC that developed in the FL stimulated cultures were first tested by stimulation by CpG in fresh culture medium, the pDC from total BM produced IFNα, the pDC derived via the myeloid route from CMP or CDP produced higher levels of IFNα, but the CLP derived pDC appeared inactive (Fig. 6a) . However the CLP derived pDC
For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From were found to be dead after overnight culture in the fresh medium of these assays, suggesting cell death due to lack of some survival factor may have been the reason for the failure to produce IFNα. The capacity of CLP-derived pDC to respond to CpG stimulation and produce IFNα was therefore tested under other conditions. Since the pDC were viable in the original cultures, the CpG stimulation experiments were repeated in conditioned medium recovered from day 7 FL stimulated BM cultures; this medium was found to be free of IFNα. The pDC generated from both CLP and CMP survived under these re-culture conditions and both responded to CpG stimulation by upregulation of CD69, indicating that they had a functioning TLR9; importantly, both then produced IFNα, although the CLP-derived pDC produced less (Fig. 6b) . Despite showing a similar initial viability (92% for CLP-derived pDC, 96% for CMP-derived pDC, based on PI exclusion) the CLP-derived pDC showed reduced viability by the time of supernatant harvest (28% for CLP-derived pDC, compared to 67% for CMP-derived pDC). This difference in viability may account for the differential IFNα production. To check that pDC developing by the lymphoid route in vivo were interferon-producing cells, CLP were purified and transferred into irradiated congenic recipients, the pDC progeny isolated 7
days after transfer and then tested for IFNα production after CpG stimulation in culture.
These pDC derived from CLP in vivo upregulated CD69 and produced IFNα, even when stimulated in fresh culture medium (Fig. 6c) . We concluded that pDC derived from both myeloid and lymphoid routes are IFN producing cells and so can be considered as 'true' functional plasmacytoid cells.
Discussion
The earlier findings that both CMP and CLP populations from mouse BM have the potential to produce pDC on adoptive transfer to irradiated mice 7 led to the original concept that pDC might in steady state be produced by both myeloid and lymphoid routes. However, since both these precursor populations show heterogeneity and CMP as isolated are able to produce some B cells on transfer to irradiated recipients 7, 21 , doubt may be cast on this interpretation. The presence of D-J rearranged IgH genes in some but not all normal mouse spleen pDC 9,10 seemed to support the dual origin hypothesis, since these DNA changes serve as an indelible marker of a past rearrangement process normally restricted to lymphoid lineage cells. However, this has also been interpreted as an "ectopic" event that occurs even with a myeloid pDC origin 12 , since in forming pDC transcriptional programs similar to those involved in B cell development must be activated. We now use a culture system that produces DC similar to those found in spleen 14 to demonstrate that indeed separate pathways, with separate intermediate precursors, are involved in pDC development. We also reconcile the two interpretations of the origin of the D-J IgH gene rearrangements in pDC.
One pathway to pDC had already been documented by the detailed studies in this and other laboratories on DC development 13, 14 . It begins with a myeloid precursor (CMP), proceeds via a DC-restricted CDP, which eventually produces both pDC and cDC.
Another pathway we now delineate begins with a lymphoid precursor (CLP) and produces pDC but few cDC. This pathway proceeds via a precursor resembling a pro-B , suggesting that pDC absolutely require E2-2 to develop, regardless of the pathway by which they differentiate.
In our model multiple separate pathways of hematopoietic development converge to produce cells that would be classified as pDC. The important question is whether these pDC products are identical, apart from the DNA changes at the IgH locus. We find they are similar in surface phenotype. Importantly we find that all pDC produced in our cultures are able to produce INFα in response to CpG stimulation, regardless of lymphoid or myeloid origin. Therefore as well as having the characteristic surface phenotype, they meet the main functional criterion of pDC.
We found that pDC derived from CLP appear to produce less IFNα in the assay cultures than pDC derived from CMP. Similar differences have been reported between RAG1 + and RAG1 -pDC from spleen 9 .
In addition there are a number of recent reports of cells with a pDC surface phenotype that differ in their capacity to make IFNα [24] [25] [26] [27] . Important in this context is our finding of one set of conditions under which CLP derived pDC failed completely to produce IFNα, due to a high rate of pDC death. This reflected a requirement for a particular survival factors in the assay rather than incapacity to produce IFNα. Overall our study emphasizes that differences in cytokine production between pDC populations may be due to differences in survival in the assay culture, or slightly different maturation or activation states, rather than due to fundamental functional differences.
More extensive functional analysis and gene expression profiling would be needed to determine if there are any important functional differences between pDC differing in lineage origin. Error bars show mean ± SEM.
